A major legal battle erupted after passage of One Big Beautiful Bill Act (OBBB) in July 2025, when Congress included a provision (Section 71113) that bars Medicaid reimbursements to certain health‑care providers — notably affiliates of Planned Parenthood — if they meet specified criteria (non‑profit status, provide abortions, and received over $800,000 in Medicaid payments in 2023).  Supporters argue Congress has sole authority over how federal funds are allocated and that no private group has a guaranteed entitlement to taxpayer dollars. Opponents contend the provision is a politically motivated attempt to defund a disfavored provider, jeopardizing access to a wide range of reproductive and preventive health services for low‑income patients.

Within days of the law’s enactment, Planned Parenthood and several affiliates filed suit; on July 28, 2025, a federal court — presided by Indira Talwani — granted a preliminary injunction blocking the funding cut, warning that the law threatened contraception, cancer screenings, STI treatments and other essential services for millions relying on Medicaid. The ruling quickly sparked political uproar: supporters of the law accused the judiciary of encroaching on Congress’s appropriations power, while critics warned the defunding could devastate health care access for vulnerable populations.

The case escalated when, on September 11, 2025, the First U.S. Circuit Court of Appeals stayed the district court’s injunction. The appeals panel determined the government met its legal burden to pause the block during ongoing litigation, thereby allowing Medicaid funds to be cut from Planned Parenthood affiliates while the case continued.  For supporters of the law, the decision underscored Congress’s constitutional prerogative to direct federal spending; for opponents, it marked a dangerous rollback of reproductive and preventive care access at a time of high uncertainty.

In the weeks following, a coalition of 22 states plus the District of Columbia sued the federal government — arguing the law’s vague definition of “prohibited entities” imposed an undue administrative burden on states responsible for Medicaid implementation. On December 2, 2025, Judge Talwani issued another injunction blocking enforcement of the provision for those states. But once again, the First Circuit acted swiftly — issuing a temporary administrative stay that kept the funding restriction enforceable while the appeal proceeds. The repeated pattern — injunction followed by appellate stay — has deepened instability and uncertainty for providers, states, and Medicaid‑dependent patients.

At the heart of the dispute lies a fundamental constitutional question: does Congress have the exclusive authority to shape federal spending, or can courts — interpreting constitutional protections — limit how that authority is exercised? Supporters of the law point out that appropriations have always been Congress’s domain, and courts should not second‑guess political decisions about funding priorities. Critics argue that when funding conditions effectively deny essential care to vulnerable populations, courts have a duty to protect constitutional rights — including equal protection, due process, and freedom from punitive targeting of specific organizations. Because the provision almost exclusively affects Planned Parenthood affiliates, opponents contend it amounts to an unconstitutional targeting, or even a forbidden bill of attainder.

With no final ruling yet, the litigation’s trajectory remains uncertain. Possible outcomes include appellate affirmation of the law, a narrow remand to clarify its terms, or adjustments by Congress — potentially forcing clearer language on who qualifies as a “prohibited entity.” Regardless of how judges rule, the case is shaping the future of federal funding conditions, state Medicaid operations, and judicial oversight of politically sensitive appropriations. The repeated court reversals and shifting injunctions have already caused real disruption: some clinics closed, patients lost care access, and states scrambled to compensate with non‑federal funds.

The ultimate resolution could set powerful precedent — not only for reproductive health funding, but for how the federal government uses conditional funding to shape public policy.